effect
growth
hormone
hypothalamopituitary
dwarfism
i
metabolic
effects
human
growth
hormone
human
growth
hormone
isolated
rabens
method
given
mg
daily
doses
periods
days
patients
pituitaryhypothalamic
dwarfism
metabolic
effects
follows
nitrogen
retention
a
variable
reduction
blood
urea
plasma
aminoacid
concentration
alter
i.m
injection
hormone
fasting
accompanying
retention
intracellular
components
proportions
required
protoplasm
formation
isotonic
expansion
extracellular
compartment
without
change
plasma
electrolyte
concentrations
retention
phosphorus
sometimes
a
rise
plasma
phosphate
increased
intestinal
calcium
absorption
hypercalciuria
alteration
plasma
calcium
increase
plasma
citrate
citrate
urinary
excretion
calcium
phosphate
retention
reversed
stopping
treatment
mobilisation
fat
stores
lipid
catabolism
accompanied
a
well
marked
increase
nefa
concentration
hours
hormone
injection
fasting
state
a
period
hypoglycaemia
low
nefa
levels
a
complex
biphasic
action
glucose
metabolism
fasting
blood
sugar
levels
altered
glycaemia
various
tests
fasting
insulin
injections
tolbutamide
administration
intestinal
hyperglycaemia
acceleration
intermediate
metabolism
increased
blood
citrate
concentrations
hours
urinary
excretion
ketoglutaric
acid
one
test
fasting
blood
citrate
increased
hours
hormone
injection
oral
load
sugar
blood
citrate
ketoglutaric
acid
concentrations
alter
a
progressive
gain
weight
found
treatment
partly
reversible
stopping
treatment
correlating
intracellular
nitrogen
retention
expansion
extracellular
space
despite
mobilisation
fat
reserves
